http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101550677-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0682 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70575 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 |
filingDate | 2013-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101550677-B1 |
titleOfInvention | Highly efficient production methods of fusion proteins for antibody treatment using catechin |
abstract | The present invention relates to a highly efficient production method of therapeutic antibody fusion protein using catechin. A pAD11 expression vector expressing a TNFR-Fc fusion protein was prepared, and cell lines having high productivity were transformed into a cell line, , The content of misfolded protein and high molecular weight aggregate can be reduced to thereby produce TNFR-Fc fusion protein with high efficiency. |
priorityDate | 2013-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 486.